$AVRW News: The Sera Labs, Inc. Announces Partners
Post# of 26594
Persky To Also Join Brand's Medical Advisory Board for Future Innovation
SHERMAN OAKS, CA / ACCESSWIRE / September 12, 2023 / The Sera Labs, Inc. ("Sera Labs"
![](/images/icons/icon_wink.gif)
![](/images/icons/icon_wink.gif)
Board-certified and fellowship-trained, Dr. Persky has specialized in facial plastic surgery for almost 40 years. Throughout his career, Dr. Persky has prioritized non-invasive and non-surgical procedures wherever possible and is always looking for products to recommend to patients before they commit to an invasive surgical procedure.
This partnership came about through a long-standing relationship with Nancy Duitch, Avenir CEO and Founder of Sera Labs. In this role, Dr. Persky will support brand marketing, social, and advertising campaigns for the brand's latest innovation, patent-pending DNA (Deep Nano Actives) Complex, an instant anti-aging skin tightening serum that penetrates deep into the skin. As an advisory board member, Dr. Persky will also advise on formulating the brand's future plant-based and scientifically grounded products.
"This is the first time that I'm endorsing an over-the-counter skincare product, and what's convinced me to do so is the science behind it, the peptide technology, and my personal experience with it," said Dr. Michael Persky. "I'm all about the truth and can't recommend something unless it's safe, effective, and helps people."
Michael A. Persky, M.D., F.A.C.S.
Facial Plastic Surgeon
The Sera Labs, Inc. Medical Advisory Board
"We are thrilled to bring on Dr. Michael Persky to help us bring more awareness to our most recent innovation, DNA Complex, and advise on the future of our brand portfolio," said CEO Nancy Duitch. "The consumer response and demand thus far for DNA Complex has been overwhelmingly positive. And now, we are excited to continue to grow awareness for this revolutionary product that provides notable results within minutes. Dr. Persky's expertise helps us to offer consumers a non-invasive alternative, continuing the democratization of skincare and our brand's mission of meeting the consumer where they are at."
DNA Complex retails at $99.99 and is currently available for purchase at: https://seralabshealth.com/pages/introducing-dna-complex
About Avenir Wellness Solutions, Inc.
Avenir Wellness (OTC PINK: AVRW) is a broad platform technology company that develops proprietary wellness, nutraceutical, and topical delivery systems. The technology, which is based on fifteen current patents, offers a number of unique immediate- and controlled-release delivery vehicles designed to improve product efficacy, safety, and consumer experience for a wide range of active ingredients. The Company will continue down the path of creating new technologies that is part of its incubator strategy in order to monetize its intellectual property by expanding its product lines utilizing the technology. And, as a vertically integrated platform company, Avenir also looks to partner or license its IP technology with wellness companies worldwide. For more information visit: www.avenirwellness.com.
About The Sera Labs, Inc.
The Sera Labs, Inc. ("Sera Labs"
![](/images/icons/icon_wink.gif)
Forward Looking Statement
This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, which statements are subject to considerable risks and uncertainties. Forward-looking statements include all statements other than statements of historical fact contained in this press release, including statements regarding the future growth and success of our organization. We have attempted to identify forward-looking statements by using words such as "anticipate," "believe," "could," "estimate," "expected," "intend," "may," "plan," "predict," "project," "should," "will," or "would," and similar expressions or the negative of these expressions.
Forward-looking statements represent our management's current expectations and predictions about trends affecting our business and industry and are based on information available as of the time such statements are made. Although we do not make forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy or completeness. Forward-looking statements involve numerous known and unknown risks, uncertainties and other factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance or achievements predicted, assumed or implied by the forward-looking statements. Some of the risks and uncertainties that may cause our actual results to materially differ from those expressed or implied by these forward-looking statements are described in the section entitled "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022, as well as in our Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission.
Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. Except as required by applicable law, we expressly disclaim any intent or obligation to update any forward-looking statements, or to update the reasons actual results could differ materially from those expressed or implied by these forward-looking statements, whether to conform such statements to actual results or changes in our expectations, or as a result of the availability of new information.
Contacts:
Media
Autumn Communications
E: seratopical@autumncommunications.com
T: (212) 206-9780
Investor Relations
Hanover International Inc.
E: investor@avenirwellness.com
T: (760) 564-7400
SOURCE: Avenir Wellness Solutions, Inc. (f/k/a Cure Pharmaceutical Holding Corp.)
View source version on accesswire.com:
https://www.accesswire.com/783058/the-sera-la...uct-launch
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)